Patients with CVID Could Benefit from New Imaging Technique
By Andrew Deutsch Posted on 08 Dec 2016 |
Image: FDG PET-CT chest imaging in a patient with GLILD - FDG uptake is represented by color intensity (Photo courtesy of S. Jolles, University Hospital of Wales).
An imaging technique using the tracer FDG (fluorodeoxyglucose) together with PET-CT imaging could be used to help patients with inflammatory complications of immunodeficiency disease.
The new proof of concept study found that FDG PET-CT (Positron Emission Tomography/Computed Tomography) could help assess inflammatory complications of Common Variable Immuno-Deficiency (CVID) and other immunodeficiency diseases and treatments. The study was published in the November 2016 issue of the Clinical & Experimental Immunology journal.
The study was carried out by researchers at the University Hospital of Wales (Wales, UK). The researchers used FDG PET-CT to simultaneously assess anatomical structure and metabolic activity in patients with Granulomatous Lymphocytic Interstitial Lung Disease (GLILD). The technique enables a detailed CT scan to be combined with PET images, as an additional layer. The results showed that FDG PET-CT could provide new insights into GLILD before and after treatment, and could be used for other inflammatory disorders as well.
Lead researcher of the study, Dr. Stephen Jolles, University Hospital of Wales, said, "Patients who develop granulomatous lymphocytic interstitial lung disease (GLILD) as a complication of common variable immunodeficiency often have poorer outcomes. Given the multi-systemic nature of this disease, it is currently difficult for clinicians to accurately monitor and assess the optimal timing of treatment as well as the effect of treatment and its duration. This study is the first time that the imaging technique, FDG PET-CT, has been used to assess the combined lung structure and metabolic activity in a patient with GLILD before and after treatment. The images are striking and enlightening in that they reveal the highly metabolically active multi-systemic nature of the disease. It remains to me amazing the ability of this technique to overlay structure with metabolic functional activity in this way."
Related Links:
University Hospital of Wales
The new proof of concept study found that FDG PET-CT (Positron Emission Tomography/Computed Tomography) could help assess inflammatory complications of Common Variable Immuno-Deficiency (CVID) and other immunodeficiency diseases and treatments. The study was published in the November 2016 issue of the Clinical & Experimental Immunology journal.
The study was carried out by researchers at the University Hospital of Wales (Wales, UK). The researchers used FDG PET-CT to simultaneously assess anatomical structure and metabolic activity in patients with Granulomatous Lymphocytic Interstitial Lung Disease (GLILD). The technique enables a detailed CT scan to be combined with PET images, as an additional layer. The results showed that FDG PET-CT could provide new insights into GLILD before and after treatment, and could be used for other inflammatory disorders as well.
Lead researcher of the study, Dr. Stephen Jolles, University Hospital of Wales, said, "Patients who develop granulomatous lymphocytic interstitial lung disease (GLILD) as a complication of common variable immunodeficiency often have poorer outcomes. Given the multi-systemic nature of this disease, it is currently difficult for clinicians to accurately monitor and assess the optimal timing of treatment as well as the effect of treatment and its duration. This study is the first time that the imaging technique, FDG PET-CT, has been used to assess the combined lung structure and metabolic activity in a patient with GLILD before and after treatment. The images are striking and enlightening in that they reveal the highly metabolically active multi-systemic nature of the disease. It remains to me amazing the ability of this technique to overlay structure with metabolic functional activity in this way."
Related Links:
University Hospital of Wales
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment